/ /

  • linkedin
  • Increase Font
  • Sharebar

    Key strategies for treating postsurgical CME

    Current concepts analysis for preserving vision in Cystoid macular edema patients


    Treatment begins with a careful evaluation of the patient, Dr. Warren said. In some cases, there are obvious causes for inflammation and blurring. Common problems include:

    • Vitreous prolapse
    • Peaked pupils
    • Vitreous around the IOL
    • Misplacement or migration of the IOL

    Every patient should have ocular coherence tomography and color photography of the retina. Any retinal thickening is significant, Dr. Warren noted. Patients with a history of diabetes or some other condition that could affect the retinal vasculature may also benefit from evaluation with fluorescein angiography.

    “OCT is highly sensitive and allows us to measure even small changes in the retina,” Dr. Warren said. “More importantly, it allows us to monitor how well the patient is responding to treatment. I can watch the swelling go from worse to better with treatment or from worse to no change. OCT is the best way to image patients to tell whether treatment is working or not.”

    Analyzing current practices

    Corticosteroids have long been the treatment of choice for ocular inflammatory disease, including CME. In vascular disease such as diabetes and CRVO, corticosteroids block vascular endothelial growth factors. In primary inflammatory disease and surgical trauma, they inhibit inflammatory cells and their mediators. The net effect is to reduce inflammation and macular edema.

    Prednisolone is the most familiar agent, but topical difluprednate offers better penetration and may spare patients from the need for periocular and intraocular injections.

    Next: Combo therapy explored as alternative

    New Call-to-action


    You must be signed in to leave a comment. Registering is fast and free!

    All comments must follow the ModernMedicine Network community rules and terms of use, and will be moderated. ModernMedicine reserves the right to use the comments we receive, in whole or in part,in any medium. See also the Terms of Use, Privacy Policy and Community FAQ.

    • No comments available


    View Results